IP Verse

Mylan Pharmaceuticals Inc. et al. v. Regeneron Pharmaceuticals, Inc. - IPR2023-00099

Explore the PTAB proceeding IPR2023-00099 filed by Mylan Pharmaceuticals Inc. et al. against Regeneron Pharmaceuticals, Inc. on Oct 28, 2022. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2023-00099
Filing Date
Oct 28, 2022
Petitioner
Mylan Pharmaceuticals Inc. et al.
Respondent
Regeneron Pharmaceuticals, Inc.
Status
Institution Denied
Respondent Application Number
16055847
Respondent Tech Center
1600
Respondent Patent Number
10857205
Institution Decision Date
Mar 1, 2023
Termination Date
Mar 1, 2023

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2023-00099.

TypeName
Petitioner CounselMolino, Paulet al
Respondent CounselBrausa, Adamet al

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.